Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-11-19 Sale |
2021-11-19 09:58 am |
Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer |
34,250 | $8.5 | $291,125 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-06-06 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Andrews William T. Chief Medical Officer |
0 | $0 | 139,708 (Direct) |
View |
2021-08-02 Option Award |
2021-08-04 4:09 pm |
N/A 2031-08-01 |
Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer |
239,750 | $0 | 239,750 (Direct) |
View |
2020-10-12 Equity Swap |
2020-10-13 3:56 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | Andrews William T. Chief Medical Officer |
37,500 | $18.15 | 0 (Direct) |
View |
2020-07-09 Option Award |
2020-07-10 5:31 pm |
N/A 2030-07-08 |
AKCEA THERAPEUTICS INC. | AKCA | Andrews William T. Chief Medical Officer |
287,500 | $0 | 287,500 (Direct) |
View |